With $3 trillion of stimulus money already disbursed and $3 trillion more scheduled to be distributed to the American people in the near future, we're taking a look at the type of oversight provisions included in the CARES Act that allow the Federal government to police COVID relief money.
Subscribe on Apple Podcasts, Google Play or Stitcher to receive every new episode as soon as they're published!What We Discuss in This Episode:
- How will the Federal government conduct oversight and enforcement action to ensure any money distributed under the CARES Act is used the right way?
- What are the three main oversight mechanisms built into the CARES Act?
- What is the task force established by the Department of Justice responsible for?
- Why are there real concerns about insider trading and what is the Securities and Exchange Commission doing about it?
- How is the CARES act similar to the 2008 economic crisis stimulus package?
- Who are "whistleblowers" and why is there a fear that the current economic climate might produce a great amount of whistleblowers?
- What are some areas that businesses could potentially get themselves into trouble when it comes to applying to, accepting, and handling distributed money?
- What is the Reverse False Claims Act?
- How can a business deal with a whistleblower within its own company?
- What steps should a company that receives a whistleblower complaint take to respond?
Check out Sheppard Mullin's Coronavirus Insights Portal which now aggregates the firm's various COVID-19 blog posts on a broad range of topics. Click here to view and subscribe.
Article originally published on 27 May 2020
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
